Susceptibility of germfree phagocyte oxidase- and nitric oxide svnthase 2-deficient mice defective in the production of reactive metabolites of both oxygen and nitrogen, to mucosal and systemic candidiasis of endogenous origin

被引:35
作者
Balish, E
Warner, TF
Nicholas, PJ
Paulling, EE
Westwater, C
Schofield, DA
机构
[1] Med Univ S Carolina, Dept Microbiol & Immunol, Div Mycol, Charleston, SC 29403 USA
[2] Med Univ S Carolina, Dept Stomatol, Charleston, SC 29403 USA
[3] Univ Wisconsin, Sch Med, Dept Surg Pathol, Madison, WI USA
关键词
D O I
10.1128/IAI.73.3.1313-1320.2005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Mice deficient for phagocyte oxidase (Phox) and nitric oxide synthase 2 (NOS2) (gp91(phox/-/)NOS2(-/-)), defective in the production of both reactive oxygen intermediates (ROI) and reactive nitrogen intermediates (RNI), were used to investigate the role of phagocytic cells during mucosal and systemic candidiasis of endogenous origin. The alimentary tracts of germfree mice were colonized with Candida albicans wild type or each of two hyphal signaling-defective mutants (efg1/efg1 and efg1/efg1 cph1/cph1). All Candida-colonized gp91(phox-/-)/NOS2(-/-) mice were moribund within 12 to 15 days after oral inoculation. C albicans wild-type and mutant strains colonized the alimentary tracts equally well and were able to translocate, most likely via Peyer's patches and mesenteric lymph nodes, to the internal organs and trigger the formation of abscesses; however, the wild-type and mutant strains did not survive in the abscessed murine tissues. Surprisingly, there was no significant difference in the ability of peritoneal exudate cells from gp91(phox-/-)/NOS2(-/-), NOS2(-/-), gp91(phox-/-), or immunocompetent C57BL/6 mice to kill C. albicans in vitro. This suggests that anti-Candida factors other than ROL and RNI can control the growth of C. albicans and that gp91(phox-/-)/NOS2(-/-) mice die due to the inability of the host to control its inflammatory response to Candida. Correspondingly, reverse transcription-PCR analysis showed increased expression of the cytokines gamma interferon, tumor necrosis factor alpha, and the chemokines MIP-2 and KC at the site of infection, while interleukin-15 expression remained relatively unchanged between germfree and infected tissues. These studies indicate that defects in ROI and RNI enabled C. albicans to translocate and disseminate to the internal organs, resulting in an uncontrolled immune response, severe pathology, and death; however, ROI and RNI were not required for the killing of phagocytized C. albicans, indicating that other anti-Candida factors either compensate or are sufficient for the killing of phagocytized Candida.
引用
收藏
页码:1313 / 1320
页数:8
相关论文
共 38 条
[1]  
[Anonymous], INNATE IMMUNE RESPON
[2]   Critical role of myeloperoxidase and nicotinamide adenine dinucleotide phosphate-oxidase in high-burden systemic infection of mice with Candida albicans [J].
Aratani, Y ;
Kura, F ;
Watanabe, H ;
Akagawa, H ;
Takano, Y ;
Suzuki, K ;
Dinauer, MC ;
Maeda, N ;
Koyama, H .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (12) :1833-1837
[3]  
Aratani Y, 1999, INFECT IMMUN, V67, P1828
[4]   Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient in myeloperoxidase [J].
Aratani, Y ;
Kura, F ;
Watanabe, H ;
Akagawa, H ;
Takano, Y ;
Suzuki, K ;
Maeda, N ;
Koyama, H .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (04) :1276-1279
[5]   WHATS NEW IN THE MECHANISMS OF HOST-RESISTANCE TO CANDIDA-ALBICANS INFECTION [J].
ASHMAN, RB ;
PAPADIMITRIOU, JM .
PATHOLOGY RESEARCH AND PRACTICE, 1990, 186 (04) :527-534
[6]  
Balish E, 2001, MED MYCOL, V39, P261, DOI 10.1080/mmy.39.3.261.268
[7]   MUCOSAL AND SYSTEMIC CANDIDIASIS IN CONGENITALLY IMMUNODEFICIENT MICE [J].
CANTORNA, MT ;
BALISH, E .
INFECTION AND IMMUNITY, 1990, 58 (04) :1093-1100
[8]   Crk1, a novel Cdc2-related protein kinase, is required for hyphal development and virulence in Candida albicans [J].
Chen, JY ;
Zhou, S ;
Wang, Q ;
Chen, X ;
Pan, T ;
Liu, HP .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (23) :8696-8708
[9]  
Chinen T, 1999, CLIN EXP IMMUNOL, V115, P491
[10]   Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study [J].
Diekema, DJ ;
Messer, SA ;
Brueggemann, AB ;
Coffman, SL ;
Doern, GV ;
Herwaldt, LA ;
Pfaller, MA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) :1298-1302